Teza Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,488
| Closed | -$446K | – | 435 |
|
|
2024
Q4 | $446K | Buy |
+9,488
| New | +$446K | 0.07% | 302 |
|
|
2024
Q2 | – | Sell |
-7,952
| Closed | -$558K | – | 616 |
|
|
2024
Q1 | $558K | Buy |
7,952
+5,190
| +188% | +$364K | 0.07% | 323 |
|
|
2023
Q4 | $231K | Buy |
+2,762
| New | +$231K | 0.04% | 469 |
|
|
2020
Q3 | – | Sell |
-10,372
| Closed | -$244K | – | 428 |
|
|
2020
Q2 | $244K | Buy |
+10,372
| New | +$244K | 0.05% | 445 |
|
|
2020
Q1 | – | Sell |
-39,881
| Closed | -$423K | – | 214 |
|
|
2019
Q4 | $423K | Buy |
+39,881
| New | +$423K | 0.12% | 322 |
|